Polymyxin B/trimethoprim, sold under the brand name Polytrim is an antimicrobial solution for topical ophthalmic use in the treatment of acute bacterial conjunctivitis and blepharoconjunctivitis.[1]

In 2022, it was the 252nd most commonly prescribed medication in the United States, with more than 1 million prescriptions.[2][3]

Medical uses

Polymyxin B/trimethoprim is indicated in the treatment of surface ocular bacterial infections,[4] including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus viridans, Haemophilus influenzae, and Pseudomonas aeruginosa.[1]

References

  1. ^ a b c "Polytrim (polymyxin B sulfate and trimethoprim ophthalmic solution, USP) Sterile". DailyMed. Retrieved 6 December 2024.
  2. ^ "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
  3. ^ "Polymyxin B; Trimethoprim Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.
  4. ^ Yolton DP (1992). "New antibacterial drugs for topical ophthalmic use". Optometry Clinics. 2 (4): 59–72. PMID 1286241.


Allikas: https://en.wikipedia.org/wiki/Trimethoprim/polymyxin
No tags for this post.